BRPI0907833A2 - derivado de amida e composição farmacêutica que contêm a mesma - Google Patents
derivado de amida e composição farmacêutica que contêm a mesmaInfo
- Publication number
- BRPI0907833A2 BRPI0907833A2 BRPI0907833A BRPI0907833A BRPI0907833A2 BR PI0907833 A2 BRPI0907833 A2 BR PI0907833A2 BR PI0907833 A BRPI0907833 A BR PI0907833A BR PI0907833 A BRPI0907833 A BR PI0907833A BR PI0907833 A2 BRPI0907833 A2 BR PI0907833A2
- Authority
- BR
- Brazil
- Prior art keywords
- same
- pharmaceutical composition
- composition containing
- amide derivative
- amide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008040029 | 2008-02-21 | ||
| PCT/JP2009/053011 WO2009104729A1 (ja) | 2008-02-21 | 2009-02-20 | アミド誘導体及びそれを含有する医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0907833A2 true BRPI0907833A2 (pt) | 2016-08-02 |
Family
ID=40985606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0907833A BRPI0907833A2 (pt) | 2008-02-21 | 2009-02-20 | derivado de amida e composição farmacêutica que contêm a mesma |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7906510B2 (pt) |
| EP (1) | EP2256114B1 (pt) |
| JP (1) | JP5101639B2 (pt) |
| KR (1) | KR101586507B1 (pt) |
| CN (1) | CN102015697B (pt) |
| AU (1) | AU2009216149B2 (pt) |
| BR (1) | BRPI0907833A2 (pt) |
| CA (1) | CA2713412C (pt) |
| ES (1) | ES2478042T3 (pt) |
| HK (1) | HK1145837A1 (pt) |
| IL (1) | IL207423A (pt) |
| MX (1) | MX2010009244A (pt) |
| RU (1) | RU2481343C2 (pt) |
| TW (1) | TWI423967B (pt) |
| WO (1) | WO2009104729A1 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107513044A (zh) * | 2017-09-20 | 2017-12-26 | 安徽修制药有限公司 | 一种枸橼酸莫沙必利的绿色环保合成方法 |
| WO2019131891A1 (ja) * | 2017-12-28 | 2019-07-04 | 大日本住友製薬株式会社 | 苦味がマスキングされた薬物含有粒子及び該薬物含有粒子を含む製剤 |
| JPWO2019230937A1 (ja) * | 2018-06-01 | 2021-07-01 | 大日本住友製薬株式会社 | 溶出性に優れた経口固形製剤 |
| CN110938068B (zh) * | 2019-11-06 | 2022-12-23 | 广东东阳光药业有限公司 | N-(吗啉-2-基甲基)酰胺衍生物及其用途 |
| CN115975210B (zh) * | 2023-01-14 | 2023-07-14 | 厦门立方幻境科技有限公司 | 一种医用硅胶及其制备方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK279058B6 (sk) * | 1986-04-30 | 1998-06-03 | Dainippon Pharmaceutical Co. | Substituovaný n-[(2-morfolynyl)alkyl]banzamidový d |
| JPS63264467A (ja) | 1986-04-30 | 1988-11-01 | Dainippon Pharmaceut Co Ltd | ベンズアミド誘導体 |
| US5395832A (en) * | 1991-02-15 | 1995-03-07 | Hokuriku Seiyaku Co., Ltd. | Benzamide derivatives |
| TW243449B (pt) | 1991-02-15 | 1995-03-21 | Hokuriku Pharmaceutical | |
| JPH11505815A (ja) | 1995-05-23 | 1999-05-25 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | （２−モルホリニルメチル）ベンズアミン誘導体 |
| JPH111472A (ja) | 1996-04-30 | 1999-01-06 | Dainippon Pharmaceut Co Ltd | ベンズアミド誘導体及びそれを含有する医薬組成物 |
| ES2234248T3 (es) * | 1998-04-28 | 2005-06-16 | Dainippon Pharmaceutical Co., Ltd. | Derivados de 1-(1-sustituido-4-piperidinil) metil)-4-piperidina, procedimiento de produccion de estos; composiciones medicinales que contienen estos compuestos e intermediarios de estos compuestos. |
| JP2000080081A (ja) | 1998-06-24 | 2000-03-21 | Dainippon Pharmaceut Co Ltd | １―〔（１―置換―４―ピペリジニル）メチル〕―４―ピペリジン誘導体及びそれを含有する医薬組成物 |
| JP2001122784A (ja) | 1999-10-27 | 2001-05-08 | Dainippon Pharmaceut Co Ltd | １−［（１−置換−４−ピペリジニル）メチル］−４−ピペリジン誘導体からなる医薬 |
| WO2001090081A1 (en) * | 2000-05-25 | 2001-11-29 | F. Hoffmann-La Roche Ag | Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| US6696468B2 (en) * | 2002-05-16 | 2004-02-24 | Dainippon Pharmaceutical Co., Ltd. | (s)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor |
| JP2004277318A (ja) | 2003-03-14 | 2004-10-07 | Dainippon Pharmaceut Co Ltd | １−（１−置換カルボニル−４−ピペリジニルメチル）ピペリジン誘導体およびそれを含有する医薬組成物 |
| JP2004277319A (ja) | 2003-03-14 | 2004-10-07 | Dainippon Pharmaceut Co Ltd | １−（４−ピペリジニルメチル）ピペリジニルアミド誘導体およびそれを含有する医薬組成物 |
| JP2004277320A (ja) | 2003-03-14 | 2004-10-07 | Dainippon Pharmaceut Co Ltd | １，４−ジ置換ピペリジン誘導体およびそれを含有する医薬組成物 |
| JP2005082508A (ja) | 2003-09-05 | 2005-03-31 | Dainippon Pharmaceut Co Ltd | ２−アルコキシ−６−アミノ−５−ハロゲノ−ｎ−（１−置換−４−ピペリジニル）ピリジン−３−カルボキサミド誘導体およびそれを含有する医薬組成物 |
| JP2005104896A (ja) | 2003-09-30 | 2005-04-21 | Dainippon Pharmaceut Co Ltd | ２−アルコキシ−６−アミノ−５−ハロゲノピリジン−３−カルボキサミド誘導体およびそれを含有する医薬組成物 |
| JP2005170933A (ja) | 2003-11-14 | 2005-06-30 | Dainippon Pharmaceut Co Ltd | （ｓ）−４−アミノ−５−クロロ−２−メトキシ−ｎ−［１−［１−（２−テトラヒドロフリルカルボニル）−４−ピペリジニルメチル］−４−ピペリジニル］ベンズアミドからなる医薬 |
-
2009
- 2009-02-19 TW TW098105307A patent/TWI423967B/zh active
- 2009-02-20 MX MX2010009244A patent/MX2010009244A/es active IP Right Grant
- 2009-02-20 RU RU2010138788/04A patent/RU2481343C2/ru not_active IP Right Cessation
- 2009-02-20 BR BRPI0907833A patent/BRPI0907833A2/pt not_active IP Right Cessation
- 2009-02-20 ES ES09711609.9T patent/ES2478042T3/es active Active
- 2009-02-20 EP EP09711609.9A patent/EP2256114B1/en not_active Not-in-force
- 2009-02-20 CN CN200980114696.8A patent/CN102015697B/zh not_active Expired - Fee Related
- 2009-02-20 AU AU2009216149A patent/AU2009216149B2/en not_active Ceased
- 2009-02-20 KR KR1020107017907A patent/KR101586507B1/ko active IP Right Grant
- 2009-02-20 CA CA2713412A patent/CA2713412C/en active Active
- 2009-02-20 JP JP2009554392A patent/JP5101639B2/ja not_active Expired - Fee Related
- 2009-02-20 WO PCT/JP2009/053011 patent/WO2009104729A1/ja active Application Filing
- 2009-02-20 US US12/734,224 patent/US7906510B2/en active Active
-
2010
- 2010-08-05 IL IL207423A patent/IL207423A/en not_active IP Right Cessation
-
2011
- 2011-01-05 HK HK11100055.9A patent/HK1145837A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2010138788A (ru) | 2012-03-27 |
| JPWO2009104729A1 (ja) | 2011-06-23 |
| HK1145837A1 (en) | 2011-05-06 |
| TWI423967B (zh) | 2014-01-21 |
| IL207423A (en) | 2016-06-30 |
| IL207423A0 (en) | 2010-12-30 |
| US7906510B2 (en) | 2011-03-15 |
| KR101586507B1 (ko) | 2016-01-19 |
| AU2009216149A1 (en) | 2009-08-27 |
| EP2256114A4 (en) | 2012-05-09 |
| CA2713412A1 (en) | 2009-08-27 |
| KR20100126684A (ko) | 2010-12-02 |
| EP2256114A1 (en) | 2010-12-01 |
| CA2713412C (en) | 2016-03-22 |
| RU2481343C2 (ru) | 2013-05-10 |
| JP5101639B2 (ja) | 2012-12-19 |
| AU2009216149B2 (en) | 2013-05-23 |
| ES2478042T3 (es) | 2014-07-18 |
| US20100249399A1 (en) | 2010-09-30 |
| MX2010009244A (es) | 2010-09-24 |
| EP2256114B1 (en) | 2014-06-25 |
| TW200951129A (en) | 2009-12-16 |
| WO2009104729A1 (ja) | 2009-08-27 |
| CN102015697A (zh) | 2011-04-13 |
| CN102015697B (zh) | 2015-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTPA2018014I1 (lt) | Farmacinė kompozicija 514 | |
| LTPA2018005I1 (lt) | Farmacinė kompozicija | |
| BRPI0715712A2 (pt) | Composição farmacêutica | |
| BRPI0721651A2 (pt) | Composição farmacêutica | |
| BRPI0719393A2 (pt) | Composição farmacêutica | |
| BRPI0810928A2 (pt) | "composição farmacêutica" | |
| DK2041139T3 (da) | Farmaceutiske forbindelser | |
| BRPI0811612A2 (pt) | Composições farmacêuticas que contêm agonista ppardelta | |
| BRPI0815190A2 (pt) | Composto derivado de piridina, composição farmacêutica que o compreende e uso do mesmo | |
| BRPI0716445A2 (pt) | composiÇço farmacÊutica | |
| BRPI0720234A2 (pt) | Composição farmacêutica | |
| DK2120884T3 (da) | Farmaceutisk sammensætning | |
| BRPI0819232A2 (pt) | composto heterocíclico e composição farmacêutica do mesmo | |
| BRPI0809661A2 (pt) | Composição farmacêutica estabilizada contendo pregabalina | |
| BRPI0908132A2 (pt) | Composto de benzodiazepina e composição farmacêutica | |
| DK2285413T3 (da) | Farmaceutisk sammensætning | |
| ES2465478T8 (es) | Composiciones farmacéuticas que comprenden brivaracetam | |
| BRPI0916571A2 (pt) | composto derivado de alquilaminometiloxazolidinona tricíclo, medicamento e composição farmacêutica que o contém e uso do composto | |
| BRPI0810399A2 (pt) | Composto, composição farmacêutica que o contém e uso do mesmo | |
| BRPI0921313A2 (pt) | composição farmaucêutica | |
| BRPI0912118A2 (pt) | composto, composição farmacêutica, e, intermediário sintético | |
| DE602008005137D1 (de) | Chinolonverbindung und pharmazeutische zusammensetzung | |
| BRPI0912171A2 (pt) | composição farmacêutica | |
| BRPI0806938A2 (pt) | Composição farmacêutica contedo um derivado de camptotecina | |
| BRPI0907833A2 (pt) | derivado de amida e composição farmacêutica que contêm a mesma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved |
Owner name: SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2450 DE 19-12-2017 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |